Constellium filed the required disclosure with the Securities and Exchange Commission regarding share purchases.
1 report, 1 independent
Updated Jun 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Constellium filed the required disclosure with the Securities and Exchange Commission regarding share purchases.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Constellium
French aluminium products manufacturer
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
- FDA completed mid-cycle review of INO-3107, and Inovio Pharmaceuticals announced the appointment of EY as its independent registered public accounting firm.
- Multiple major financial firms, including Jane Street, Grayscale Investments, Andreessen Horowitz, and Charles Schwab, submitted comments to the SEC regarding the review of ETFs.
Related events
- ImmunityBio must disclose its holdings in compliance with SEC filing requirements.
- The Securities and Exchange Commission (SEC) has issued a requirement regarding the disclosure of fund purchases.
- Iron Horse Acquisitions II Corp. filed disclosures with the Securities and Exchange Commission on September 14, 2026.
- Disclosure made to the Securities and Exchange Commission involving Northern Trust on July 2, 2026.
- Qualcomm filed required disclosures regarding institutional stake purchases with the Securities and Exchange Commission.